Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 20 results for "daiichi sankyo"

Daiichi-Singh brothers feud: More about arbitration, than about compensation
Money Today

Daiichi says Singh brothers' asset declarations false

Daiichi Sankyo made its fourth attempt in the Delhi High Court on Monday to secure the assets of Malvinder Singh and Shivinder Singh (and their affiliate companies), after claiming that the former Ranbaxy promoters had made false statements in earlier ... Business Standard, 3 days ago

44 images for daiichi sankyo

PharmaVOICE, 2 months ago
VC Circle, 2 months ago
Financial Express, 2 months ago
Nasdaq, 1 month ago, 2 months ago
Pharma Live, 2 months ago
Money Today, 2 months ago
PharmaVOICE, 3 months ago
Pharmaceutical, 2 months ago
Financial Express, 2 months ago

Daiichi moves Delhi HC again to ban Fortis from selling stakes

Tension between Japanese drugmaker Daiichi Sankyo and Singh brothers of Fortis Healthcare is rising as the former has again moved the Delhi High Court against Fortis on March 6.
 Money Control3 weeks ago Daiichi case: HC asks Singh bros to declare value of total stake  Money Control1 month ago No stay on Fortis stake sale plan yet  Business Line2 months ago Delhi HC to consider Singh bros-Daiichi case over Ranbaxy on Jan 23  Business Line2 months ago

Daiichi Sankyo says Sayonara to India; terminates contract of 170 employees

The company's closure of R&D establishment in Gurgaon marks its exit from Indian market
 Business Standard2 months ago Daiichi to shut down Indian RD centre; 170 employees impacted  Money Control2 months ago

Daiichi Sankyo stumps industry with move to pull the plug on Indian Research and development arm

E Kumar Sharma New Delhi Last Updated: January 18, 2017 | 16:43 IST On January 10th, in a 100 word press release, Japanese pharma major Daiichi Sankyo announced that the company had decided to "to close its research subsidiary, Daiichi Sankyo India Pharma ...
 Money Today2 months ago
Business Standard

Lupin receives US FDA nod for generic Evoxac capsule

Evoxac capsule, marketed by Daiichi Sankyo, had recorded sales of $ 40.8 million in the US January 3, 2017 Last Updated at 10:15 IST RECOMMENDED FOR YOU Subscribe to the Business Standard b2b Connect Newsletters and stay updated with latest news, features, ...
 Business Standard2 months ago Lupin receives FDA nod for generic Evoxac Capsules  India Infoline2 months ago

Kite Pharma partners with Japan's Daiichi for cancer therapy

Kite Pharma Inc said on Monday it partnered with Daiichi Sankyo Co Ltd to develop and commercialize its cancer treatment therapy in Japan, putting the U.S. company in line to receive up to $250 million in payments. The company will also receive low to mid ...
 Reuters2 months ago

Delhi HC restricts former Ranbaxy promoters from selling assets

The Delhi High Court on Monday ordered former Ranbaxy promoters Malvinder Singh and Shivinder Singh not to part with any unencumbered (charge-free) assets without first approaching the court in a bid to secure funds for a Rs 2,562 crore Singapore arbitration ...
 Business Standard2 weeks ago Delhi HC sets terms for former Ranbaxy promoters' sale of free assets  Business Standard2 weeks ago

Sensex Ends Dull on First Trading Day of 2017; Realty Index Surges 4.3%

Posted by Equitymaster The Indian share markets started the new year's trading day on a dull note. At the closing bell, the BSE Sensex closed lower by 31 points, whereas the NSE Nifty finished lower by 6 points. The S&P BSE Midcap ended up by 0.8% while the ...
 Equitymaster.com2 months ago

Sensex Opens Flat; IT & Pharma Stocks Top Gainers

Posted by Equitymaster Asian markets are lower today as Japanese and Hong Kong shares fall. The Nikkei 225 is off 0.03% while the Hang Seng is down 0.09%. The Shanghai Composite is trading down by 0.28%. Stock markets in the US and Europe closed their ...
 Equitymaster.com2 months ago
India Infoline

Lupin gets tentative approval for generic Benicar tablets; stocks up 1%

line News Service | Mumbai | December 26, 2016 11:15 IST Lupin’s Olmesartan Medoximil tablets 5mg, 20 mg and 40 mg are the AB rated generic equivalents of Daiichi Sankyo Inc’s Benicar tablets, 5 mg, 20 mg and 40 mg.
 India Infoline2 months ago Lupin receives tentative approval for generic Benicar tablets  Money Control2 months ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less